A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease

Chronic Kidney Diseases Clinical Trial

Official title:

Taking an Active Role in Your Own Healthcare: A Delphi Survey for Key Stakeholders to Identify Priority Self-management Outcomes for Chronic Kidney Disease (SM-CKD Delphi Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05991726
• Other study ID #: 33721
• Status: Completed
• Start date: May 5, 2022
• Est. completion date: April 3, 2023

Study information

• Verified date: August 2023
• Source: University of Leicester
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this Delphi study is to identify priority outcomes for self-management in earlier (non-dialysis) stages of CKD from the perspectives of different stakeholder groups in the UK. The findings of this study will be used to inform outcome measure selection for research and clinical evaluations of self-management resources and to support implementation, commissioning and uptake.

Description:

Chronic Kidney Disease (CKD) is a progressive condition affecting more than 1.8 million people in England

Effective self-management is important for people living with CKD like many Long-Term Conditions. Self-management in its broadest term can be summarised as individuals participating in the day-to-day management of their chronic condition

Theory- and evidence-based tools and resources for self-management education and support are required to encourage health-promoting behaviours. However, outcomes valued by key stakeholders are necessary to ensure robust evaluation in research settings and clinical practice

A Delphi study is carried out to generate consensus on outcomes that are valued by the stakeholder groups in this study. The Delphi study will undergo 3-4 survey rounds

Adult CKD patient participants living in the UK and their significant others were recruited via social media adverts shared by our research team and English kidney community organisations. Healthcare professionals, commissioners and policymakers (professional groups) based in the UK were recruited by direct email invitations to our extensive contacts in the field

Recruitment information / eligibility

• Status: Completed
• Enrollment: 140
• Est. completion date: April 3, 2023
• Est. primary completion date: April 3, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• People with diagnosis of CKD in the UK

• Their close family and friend

• Healthcare professionals who look after people with CKD in the UK

• Anyone involved in designing, developing, managing and commissioning CKD healthcare services in the UK

• Researchers related in a topic related to self-management or CKD

Exclusion Criteria:

• Any participant residing outside of the UK

Related Conditions & MeSH terms

• Chronic Kidney Diseases
• Kidney Diseases
• Renal Insufficiency, Chronic

Intervention

Other:
• Other: Survey
Multiple survey rounds identifying most important outcomes for effective self-management for non-dialysis CKD

Locations

Country	Name	City	State
United Kingdom	University of Leicester	Leicester

Sponsors (1)

Lead Sponsor	Collaborator
University of Leicester

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Open ended free text question	Round 1- Participants are asked to describe the 3 most important outcomes for self-management in people with non-dialysis CKD from their own perspective or opinion	Between 3 to 6 month
Primary	Consensus Rating	Round 2- Participants are asked to rate each item on a 9 point Likert-type scale, the lowest scoring items are removed (consensus is predefined as = 70% on each item scoring on the critical importance scale that is a score of 7-9).	Between 3 to 6 month
Primary	Consensus Ranking	Round 3- Participants are asked to rank each item and themes in order from high to low importance to identify the most valued outcomes	Between 3 to 6 month